In vitro and in silico studies of 8(17),12E,14-labdatrien-18-oic acid in airways smooth muscle relaxation: new molecular insights about its mechanism of action.

Naunyn-Schmiedeberg's Archives of Pharmacology
Edilson B Alencar FilhoBagnólia A Silva

Abstract

In the field of experimental pharmacology, researchers continuously investigate new relaxant agents of the airway smooth muscle cells (ASMCs), since the pathophysiology of respiratory illnesses, such as asthma, involves hyperresponsiveness and changes in ASMC homeostasis. In this scenario, labdane-type diterpenes, like forskolin (FSK), are a class of compounds known for their relaxing action on smooth muscle cells (SMCs), being this phenomenon related to the direct activation of AC-cAMP-PKA pathway. Considering the continuous effort of our group to study the mechanism of action and prospecting for compounds isolated from natural sources, in this paper, we presented how the diterpene 8(17),12E,14-labdatrien-18-oic acid (LBD) promotes relaxant effect on ASMC, performing in vitro experiments using isolated guinea pig trachea and in silico molecular docking/dynamics simulations. In vitro experiments showed that in the presence of aminophylline, FSK and LBD had their relaxant effect potentiated (EC50 from 1.4 ± 0.2 × 10-5 M to 1.5 ± 0.3 × 10-6 M for LBD and from 2.0 ± 0.2 × 10-7 M to 6.4 ± 0.4 × 10-8 M for FSK) while in the presence of Rp-cAMPS this effect was attenuated (EC50 from 1.4 ± 0.2 × 10-5 M to 3 × 10-4 M for LBD and from 2...Continue Reading

References

Nov 1, 1989·Trends in Pharmacological Sciences·A LaurenzaK B Seamon
Mar 1, 1986·The American Journal of Physiology·E G McMahon, R J Paul
Dec 1, 1970·The American Journal of Physiology·B M Altura, B T Altura
Jun 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·K B SeamonJ W Daly
Feb 1, 1983·Naunyn-Schmiedeberg's Archives of Pharmacology·M J Muller, H P Baer
May 1, 1994·Clinical and Experimental Pharmacology & Physiology·T HiramatsuK Takagi
Jul 1, 1995·British Journal of Pharmacology·V A SnetkovJ P Ward
Nov 17, 1994·Nature·A P Somlyo, A V Somlyo
Apr 1, 1996·Planta medica·A RojasR Mata
Feb 1, 1997·Clinical and Experimental Pharmacology & Physiology·K MikawaK Takagi
Mar 11, 1998·Clinical and Experimental Pharmacology & Physiology·M TanizawaK Takagi
Aug 4, 1998·Molecular Pharmacology·W J Tang, J H Hurley
Jul 31, 1999·Science·J J TesmerS R Sprang
Dec 11, 1999·Nucleic Acids Research·H M BermanP E Bourne
Aug 23, 2001·Proceedings of the National Academy of Sciences of the United States of America·N A BakerJ A McCammon
Mar 22, 2003·The Journal of Pharmacology and Experimental Therapeutics·Minoru MatsuiFrederick J Ehlert
Jun 27, 2003·Cellular and Molecular Neurobiology·Paul A Insel, Rennolds S Ostrom
Mar 20, 2004·Science·William L Jorgensen
Jul 21, 2004·Journal of Computational Chemistry·Eric F PettersenThomas E Ferrin
Nov 3, 2004·Nature Reviews. Drug Discovery·Douglas B KitchenJürgen Bajorath
Jul 12, 2005·Journal of Smooth Muscle Research = Nihon Heikatsukin Gakkai Kikanshi·Yoshio TanakaKatsuo Koike
Mar 10, 2006·Vascular Pharmacology·Aldeídia Pereira de OliveiraIsac Almeida de Medeiros
Jun 8, 2006·Medicinal Research Reviews·Hernán AlonsoJill E Gready
Jul 15, 2006·Science·Olivier DellisColin W Taylor
Aug 23, 2006·Clinical and Experimental Pharmacology & Physiology·A F Dulhunty
Mar 3, 2007·Chemical & Pharmaceutical Bulletin·Yupei ShanMasatake Niwa
Aug 19, 2007·Journal of Internal Medicine·Kjell Larsson
Dec 21, 2007·Proceedings of the American Thoracic Society·Joseph A JudeMathur S Kannan
Jan 8, 2008·Chemical & Pharmaceutical Bulletin·Yupei ShanMasatake Niwa
Jul 8, 2008·Toxicology in Vitro : an International Journal Published in Association with BIBRA·S VerstraelenR Van Den Heuvel
Jan 20, 2009·American Journal of Respiratory Cell and Molecular Biology·Sejal SaglaniClare M Lloyd

❮ Previous
Next ❯

Software Mentioned

Autodock
Gaussian
Autodock Tools
Chimera
LINCS
ATB ( Automated Topology Builder )
GROMACS
GaussView
Biomed©
pdb2gmx

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.